Niina Veitonmäki
Senior director Pure Biologics
Dr. Niina Veitonmaki is a life science expert with over 20 years of experience in oncology drug discovery and development. She specializes in antibody-based therapeutics and immunotherapies, leading projects from early discovery to clinical trials. As Supervisor of Immuno-Oncology at Pure Biologics, she drives innovation in afucosylated antibodies and NK cell engagers. Niina holds a PhD in Tumor Biology from Karolinska Institutet and an MSc in Molecular Biology from Stockholm University, and has contributed to multiple clinical-stage therapies and high-impact publications.
Seminars
Thursday 4th December 2025
Exploring the Translational Validation of ADCC-Inducing Antibodies Using Humanised Models & Clinical Biomarker Integration
2:30 pm
- Applying wt and humanised in vivo platforms to assess therapeutic performance of ADCC-inducing antibodies across solid and liquid tumour types, including CLL
- Identifying and validating biomarkers from head and neck cancer patient datasets, with correlation to preclinical mouse models
- Leveraging humanised mice to bridge mechanistic insights and clinical relevance, supporting the development of targeted immunotherapies with translational impact
